SLC18A1

gene product
CGAT, VAT1, VMAT1
The vesicular monoamine transporter acts to accumulate cytosolic monoamines into vesicles, using the proton gradient maintained across the vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (Peter et al., 1993 [PubMed 7905859]). See also SLC18A2 (MIM 193001). [supplied by OMIM, Mar 2008]
More gene data

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
145 antibodies from 26 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
NovoPro Bioscience Inc.
4 antibodies
Proteintech Group
1 antibody
antibodies-online
51 antibodies
OriGene
4 antibodies
Atlas Antibodies
2 antibodies
Biorbyt
7 antibodies
Aviva Systems Biology
3 antibodies
Novus Biologicals
3 antibodies
Abnova Corporation
2 antibodies
LifeSpan BioSciences, Inc.
31 antibodies
Invitrogen Antibodies
3 antibodies
Abgent
3 antibodies
St John's Laboratory
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Affinity Biosciences
1 antibody
Boster Biological Technology
1 antibody
ProSci
2 antibodies
MyBioSource
3 antibodies
EMD Millipore
1 antibody
Sigma-Aldrich
4 antibodies
Creative Biolabs
2 antibodies
Creative Diagnostics
2 antibodies
RabMAbs
1 antibody
United States Biological
7 antibodies
Abbexa
3 antibodies
GenWay
1 antibody